Introduction: The Digital Maturity Paradox The global pharmaceutical and biopharmaceutical manufacturing sectors stand at
Introduction Supply chains in the chemical and pharmaceutical industries are becoming increasingly volatile, complex
Selectively blocking aldosterone production has been one of the harder problems in cardiovascular medicinal
Introduction Antibody–peptide conjugates (APCs) are gaining significant attention as a next-generation bioconjugate modality that
Arguably no pharma function has as complete a picture of a medicine across its
At Chemspec Europe 2026, I joined a panel with industry leaders to discuss a
Introduction Highly Potent Active Pharmaceutical Ingredients (HPAPIs) have gained strategic importance across multiple therapeutic
Introduction The manufacture of medicinal products in shared facilities is an established industrial practice,
Artificial intelligence is reshaping pharmaceuticals industry-not through generic algorithms alone, but by addressing real
In today’s rapidly evolving pharmaceutical ecosystem, the relationship between drug sponsors and their outsourced
